Data Intelligence
Cancer Insights & Benchmarking
Real-time analytics on survival trends, research volume, clinical trial density, and specialist distribution
0
Clinical Trials
0
Cancer Specialists
3
Research Papers
50+
Countries Covered
5-Year Survival Rates by Cancer Type
- Survival Rate (%)
Data Source: National Cancer Institute SEER Program. Survival rates vary based on stage at diagnosis, treatment advances, and patient demographics.
Key Insights
Best Survival Outcomes
Prostate and thyroid cancers have 97%+ 5-year survival when detected early.
Early screening is critical.
Research Leaders
Breast and lung cancer receive the most research funding and publications.
Reflects disease burden and treatment advances.
Access Hotspots
California, New York, and Texas lead in clinical trial and specialist access.
Geographic disparities remain significant.